These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22226053)

  • 1. Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight.
    Jelsing J; Vrang N; Hansen G; Raun K; Tang-Christensen M; Knudsen LB
    Diabetes Obes Metab; 2012 Jun; 14(6):531-8. PubMed ID: 22226053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
    Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
    Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study.
    Chedid V; Vijayvargiya P; Carlson P; Van Malderen K; Acosta A; Zinsmeister A; Camilleri M
    Neurogastroenterol Motil; 2018 Jul; 30(7):e13313. PubMed ID: 29488276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
    Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
    Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults.
    van Can J; Sloth B; Jensen CB; Flint A; Blaak EE; Saris WH
    Int J Obes (Lond); 2014 Jun; 38(6):784-93. PubMed ID: 23999198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.
    Sisley S; Smith K; Sandoval DA; Seeley RJ
    Peptides; 2014 Aug; 58():1-6. PubMed ID: 24879927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 receptor agonists for weight loss in adult patients without diabetes.
    Ottney A
    Am J Health Syst Pharm; 2013 Dec; 70(23):2097-103. PubMed ID: 24249759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
    McKay NJ; Kanoski SE; Hayes MR; Daniels D
    Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1755-64. PubMed ID: 21975647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin hormones and the satiation signal.
    Holst JJ
    Int J Obes (Lond); 2013 Sep; 37(9):1161-8. PubMed ID: 23295502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
    Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
    Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
    Mul JD; Begg DP; Barrera JG; Li B; Matter EK; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
    Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R68-77. PubMed ID: 23616105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 analogues exenatide and liraglutide exert inhibitory effect on the early phase of liver regeneration after partial hepatectomy in rats.
    Fontana J; Kučera O; Mezera V; Anděl M; Červinková Z
    Physiol Res; 2017 Nov; 66(5):833-844. PubMed ID: 28730824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile.
    Larsen AT; Gydesen S; Sonne N; Karsdal MA; Henriksen K
    BMC Endocr Disord; 2021 Jan; 21(1):10. PubMed ID: 33413317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes.
    Horowitz M; Flint A; Jones KL; Hindsberger C; Rasmussen MF; Kapitza C; Doran S; Jax T; Zdravkovic M; Chapman IM
    Diabetes Res Clin Pract; 2012 Aug; 97(2):258-66. PubMed ID: 22446097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms.
    Kanoski SE; Ong ZY; Fortin SM; Schlessinger ES; Grill HJ
    Diabetes Obes Metab; 2015 Mar; 17(3):285-93. PubMed ID: 25475828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog.
    Gydesen S; Andreassen KV; Hjuler ST; Hellgren LI; Karsdal MA; Henriksen K
    Am J Physiol Endocrinol Metab; 2017 Nov; 313(5):E598-E607. PubMed ID: 28292761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
    Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW
    Int J Obes (Lond); 2012 Mar; 36(3):379-84. PubMed ID: 21694700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of anti-diabetic therapy based on glucagon-like peptide-1 receptor agonists on the cardiovascular risk of patients with type 2 diabetes mellitus].
    Camafort-Babkowski M
    Med Clin (Barc); 2013 Aug; 141(4):167-74. PubMed ID: 23332622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
    Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.